OnKure Therapeutics, Inc. (OKUR)

Nasdaq: OKUR · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2018

Full chart Alerts Compare

Grade5.9

◀ Past 6.8● Present 4.4▶ Future 6.5

7 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Who owns OnKure Therapeutics, Inc.

As filed with the SEC

Holders of 5% or more

AI Biotechnology LLC holds 20% of Class A Common Stock, par value $0.0001 per share, as its SCHEDULE 13D filed Apr 7, 2026 says.

Directors and officers

report now, of 27 people on the record since 2021. Their holdings as a group are not read here.

Institutions as a whole

n/a

The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 8 named at left.

Holders of 5% or moreshare of the class, as filed

AI Biotechnology LLC

SCHEDULE 13D · filed Apr 7, 2026 · Class A Common Stock, par value $0.0001 per share

20%

RA Capital Management, L.P.

SCHEDULE 13G · filed Apr 7, 2026 · Class A Common Stock, $0.0001 par value per share

9.9%

Anders Hove

SCHEDULE 13G · filed Apr 1, 2026 · Common Stock, $0.0001 Par Value · 22.1% in May 30, 2025

9.5%

Bvf Partners L P/il

SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Common Stock, par value $0.0001 per share · 5.3% in May 27, 2026

Coastlands Capital LP

SCHEDULE 13G · filed Oct 7, 2026 · Class A Common Stock, par value $0.0001 per share

6.67%

StepStone Group LP

SCHEDULE 13G · filed Apr 7, 2026 · Class A Common Stock, par value $0.0001 per share

6.6%

Shay Capital LLC

SCHEDULE 13G · filed May 29, 2025 · Class A Common Stock, par value $0.0001 per share

6.3%

Cantor Fitzgerald Securities

SCHEDULE 13G · filed Aug 14, 2025 · Class A Common Stock, par value $0.0001 per share

5.2%

ADAR1 Capital Management, LLC

SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 6% in May 15, 2026

under 5%

The Vanguard Group

SCHEDULE 13G/A · filed Jan 30, 2026 · Common Stock · reported falling below 5%, from 5.58% in Jan 31, 2025

under 5%

Highbridge Capital Management, LLC

SCHEDULE 13G/A · filed Feb 17, 2026 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.2% in Aug 14, 2025

under 5%

Deep Track Capital, LP

SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%

under 5%

Trails Edge Capital Partners, LP

SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Common Stock, $0.0001 par value per share · reported falling below 5%, from 6% in Apr 7, 2026

under 5%

Prosight Management, LP

SCHEDULE 13G/A · filed Aug 10, 2026 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.8% in Nov 28, 2025

under 5%

Kenneth Griffin

SCHEDULE 13G/A · filed Feb 17, 2026 · Class A Common Stock, par value $0.0001 per share (the "Shares") · reported falling below 5%

under 5%

Lundbeckfond Invest A/S

SCHEDULE 13G/A · filed Feb 6, 2025 · Class A Common Stock, $0.0001 par value per share · reported falling below 5%

under 5%

John P. McKearn, Ph.D.

SCHEDULE 13D/A · filed Jan 21, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%

under 5%

Samsara BioCapital, L.P.

SCHEDULE 13G/A · filed Aug 14, 2025 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%

under 5%

Cormorant Asset Management, LP

SCHEDULE 13G/A · filed May 19, 2025 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%

under 5%

Perceptive Advisors LLC

SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%

under 5%

What OKUR reports owning in othersstakes of 5% or more, and other ties

Other ties the annual report names

Reneo

An entity · legal entity · owns, named in the 10-K filed Mar 12, 2026

2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 10, 2025.

Insider tradesForm 4

8sales

0purchases

0sales on a scheduled plan

2people selling

$0sold, in dollars

$0bought, in dollars

Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.

By calendar yearSoldBought

2122232526

2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.

People who traded in the window2 of 47 on the roster

Person	Role as filed	Sales	Sold	On a plan	Buys	Bought
Saccomano Nicholas A	President and CEO	4	$0	0	0	$0
Leverone Jason A.	Chief Financial Officer	4	$0	0	0	$0

SI Assistanton OKUR · research, not advice